In fact, Ford maintained an optimistic tone Tuesday morning when he discussed the potential relationship between GLP-1 drugs and medtech
The researchers analyzed thousands of electronic medical records of older adults with both diabetes and cancer and found that those who were taking GLP-1s had lower all-cause mortality than did those who were taking another type of diabetes medication, dipeptidyl peptidase 4 inhibitors (DPP-4i)
R.et al (1997)
For 48 hours following your treatment, refrain from heavy activity
Can I start at a higher dose
Zepbound is administered as a once-weekly subcutaneous injection, with dosing initiated at 2.5 mg for 4 weeks, then increased by 2.5 mg every 4 weeks until the target maintenance dose (5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg weekly) is reached, based on individual response and tolerability